Title : Decreased IL-6 induces sensitivity of hepatocellular carcinoma cells to sorafenib.

Pub. Date : 2019 Oct

PMID : 31387809






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Decreased IL-6 induces sensitivity of hepatocellular carcinoma cells to sorafenib. Sorafenib interleukin 6 Homo sapiens
2 Therefore, in the present study, we attempted to investigate the effect and mechanisms of IL-6 on sensitivity of HCC cells to sorafenib regarding the cell proliferation and apoptosis. Sorafenib interleukin 6 Homo sapiens
3 Furthermore, sorafenib significantly inhibited cell proliferation, IL-6 level and activation of p-PI3K/AKT while promoted the cell apoptosis rate and Caspase3 level compared as the control group, which were further promoted by administration of si IL-6. Sorafenib interleukin 6 Homo sapiens
4 Furthermore, sorafenib significantly inhibited cell proliferation, IL-6 level and activation of p-PI3K/AKT while promoted the cell apoptosis rate and Caspase3 level compared as the control group, which were further promoted by administration of si IL-6. Sorafenib interleukin 6 Homo sapiens
5 Therefore, downregulating IL-6 could be a potential treatment to increase the cell sensitivity of HCC cells to sorafenib. Sorafenib interleukin 6 Homo sapiens